Perspective Therapeutics Inc (CATX)
1.615
+0.02
(+0.94%)
USD |
NYAM |
May 20, 16:00
1.615
0.00 (0.00%)
After-Hours: 19:47
Perspective Therapeutics Cash from Financing (Quarterly): 166.33M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 166.33M |
December 31, 2023 | 0.352M |
September 30, 2023 | 0.001M |
June 30, 2023 | 0.512M |
March 31, 2023 | -0.08M |
September 30, 2022 | 0.028M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.056M |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.243M |
March 31, 2021 | 55.98M |
December 31, 2020 | 8.465M |
September 30, 2020 | |
June 30, 2020 | 0.874M |
March 31, 2020 | 0.131M |
December 31, 2019 | -0.011M |
September 30, 2019 | |
June 30, 2019 | 0.013M |
March 31, 2019 | -0.009M |
December 31, 2018 | -0.124M |
September 30, 2018 | 7.494M |
June 30, 2018 | 0.482M |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.039M |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | -0.009M |
September 30, 2016 | |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.003M |
December 31, 2015 | -0.011M |
September 30, 2015 | 0.047M |
June 30, 2015 | 0.0796M |
March 31, 2015 | 0.0004M |
December 31, 2014 | -0.0106M |
September 30, 2014 | 0.2157M |
June 30, 2014 | 0.3858M |
March 31, 2014 | 19.80M |
December 31, 2013 | -0.0122M |
September 30, 2013 | 3.281M |
June 30, 2013 | 0.0018M |
March 31, 2013 | 0.00 |
December 31, 2012 | -0.007M |
September 30, 2012 | 3.302M |
June 30, 2012 | 0.7983M |
March 31, 2012 | -0.0052M |
December 31, 2011 | 2.270M |
September 30, 2011 | 0.0402M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.08M
Minimum
Mar 2023
166.33M
Maximum
Mar 2024
13.70M
Average
0.056M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
icad Inc | -- |
Predictive Oncology Inc | -0.1113M |
Xtant Medical Holdings Inc | 5.179M |
Asensus Surgical Inc | 0.811M |
Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 13.85M |
Cash from Investing (Quarterly) | -47.30M |
Free Cash Flow | -23.28M |
Free Cash Flow Per Share (Quarterly) | 0.0096 |
Free Cash Flow Yield | -4.32% |